マイクロバイオーム解析の世界市場：市場規模・シェア・動向分析 (製品・サービス別、技術別、最終用途別、地域別)、セグメント別予測 (2025年～2030年)

マイクロバイオーム解析市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のマイクロバイオーム解析の市場規模は2030年までに22億6,000万米ドルに達し、2025年から2030年までのCAGRは10.47％で成長すると予測されています。

この成長は、個別化医療に対する需要の高まり、慢性疾患の蔓延、医薬品開発アプリケーションの拡大、シーケンシングとバイオインフォマティクスの技術進歩によってもたらされます。戦略的提携やCRO/CMOへのアウトソーシングは、研究および臨床の両領域における市場拡大をさらに加速させています。

マイクロバイオーム解析市場は、学術界、産業界、規制機関の連携強化に牽引され、急速に進化しています。データ解析、シーケンス技術、機械学習における革新は、マイクロバイオーム研究の精度と拡張性を高めています。さらに、健康と疾患におけるヒトマイクロバイオームの役割に対する理解の高まりが、マイクロバイオーム解析技術への投資と技術革新を後押ししています。この市場は、疾病診断、個別化医療、医薬品開発、栄養学研究への幅広い応用により、強い勢いを見せています。

次世代シーケンサー（NGS）、バイオインフォマティクス、メタボロミクスの進歩により、マイクロバイオーム解析の精度とアクセシビリティが大幅に向上しています。これらの開発により、研究者や臨床医は、炎症性腸疾患、肥満、糖尿病、がん、神経疾患と関連する微生物シグネチャーを明らかにすることができます。その結果、マイクロバイオーム研究は学術機関から臨床や商業的な使用事例へと移行しつつあります。

しかし、方法論が標準化されていないこと、臨床検証が限定的であること、規制があいまいであることなどが、市場の成長を抑制しています。また、高度なマルチオミクス技術や複雑なデータ解釈に伴う高コストも、普及の妨げとなっています。さらに、特に消費者直接検査におけるデータプライバシーをめぐる懸念や、結果が一貫していないことによる臨床医の懐疑的な見方が、マイクロバイオーム解析を主流のヘルスケアや診断に組み込む上での課題となっています。

マイクロバイオーム解析市場：分析概要

• 製品・サービス別では、消耗品が2024年の売上高シェア46.47%で市場を独占しています。この優位性は主に、DNA抽出、ライブラリー調製、増幅に不可欠な試薬、キット、その他の研究用資材の継続的な需要によるものです。しかし、サービスは予測期間中11.55%のCAGRで最も速く成長すると予測されています。
• 技術別では、16S rRNAシーケンスが2024年に市場をリードしました。その理由は、費用対効果、学術および臨床研究での広範な採用、多様なサンプルタイプにわたる細菌群集の同定における信頼性です。しかし、ショットガンメタゲノミクスは予測期間中に最も速いCAGRで成長すると予測されています。
• 用途別では、研究用途が2024年のマイクロバイオーム解析市場を牽引しました。この成長の原動力となっているのは、学術資金の増加とマイクロバイオームベースの疾患メカニズムに対する関心の高まりです。しかし、疾患用途は予測期間中に最も速いCAGRで成長すると予測されています。
• 最終用途別では、学術研究機関が2024年のマイクロバイオーム解析市場をリードしました。その優位性は、旺盛な研究資金、広範なマイクロバイオーム調査、高度なシーケンス技術へのアクセスに起因します。しかし、CRO&CMOは予測期間中に最も速いCAGRで成長すると予測されています。
• 地域別では、北米地域が2024年に42.81%のシェアでマイクロバイオーム解析市場を独占し、強力な研究インフラ、高いヘルスケア支出、主要市場プレーヤーと高度なシーケンス施設の存在がその原動力となっています。アジア太平洋地域は予測期間中に最も速いCAGRで成長すると予測されています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 市場の変動要因・傾向・範囲

• 市場連関の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因の分析
• マイクロバイオーム解析市場：分析ツール
  • 業界分析：ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 マイクロバイオーム解析市場：製品・サービス別のビジネス分析

• セグメントダッシュボード：製品・サービス別
• 世界のマイクロバイオーム解析市場の変動分析：製品・サービス別
• 世界のマイクロバイオーム解析の市場規模と動向分析：製品・サービス別（2018～2030年）
• 機器
• 消耗品
• サービス

第5章 マイクロバイオーム解析市場：技術別のビジネス分析

• セグメントダッシュボード：技術別
• 世界のマイクロバイオーム解析市場の変動分析：技術別
• 世界のマイクロバイオーム解析の市場規模と動向分析：技術別（2018～2030年）
• 16S rRNAシークエンシング
• ショットガンメタゲノミクス
• メタトランスクリプトミクス
• その他

第6章 マイクロバイオーム解析市場：用途別のビジネス分析

• セグメントダッシュボード：用途別
• 世界のマイクロバイオーム解析市場の変動分析：用途別
• 世界のマイクロバイオーム解析の市場規模と動向分析：用途別（2018～2030年）
• 疾患用途
• 研究用途

第7章 マイクロバイオーム解析市場：最終用途別のビジネス分析

• セグメントダッシュボード：最終用途別
• 世界のマイクロバイオーム解析市場の変動分析：最終用途別
• 世界のマイクロバイオーム解析の市場規模と動向分析：最終用途別（2018～2030年）
• バイオ医薬品・製薬会社
• CRO・CMO
• 学術研究機関
• その他

第8章 マイクロバイオーム解析市場：地域別の推定・動向分析

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • タイ
  • 韓国
  • オーストラリア
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市況分析（2024年）
• 企業プロファイル/上場企業
  • Genetic Analysis AS
  • Zymo Research Corporation
  • Microbiome Insights
  • . Viome Life Sciences, Inc.
  • Microba Life Science
  • Luxia Scientific
  • DNA Genotek
  • Sun Genomics
  • CosmosID
  • MaaT Pharma

List of Tables

• Table 1. North America microbiome analysis market estimates & forecasts
• Table 2. North America microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 3. North America microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 4. North America microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 5. North America microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 6. U.S. microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 7. U.S. microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 8. U.S. microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 9. U.S. microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 10. Canada microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 11. Canada microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 12. Canada microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 13. Canada microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 14. Mexico microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 15. Mexico microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 16. Mexico microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 17. Mexico microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 18. Europe microbiome analysis market estimates & forecasts
• Table 19. Europe microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 20. Europe microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 21. Europe microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 22. Europe microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 23. UK microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 24. UK microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 25. UK microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 26. UK microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 27. Germany microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 28. Germany microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 29. Germany microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 30. Germany microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 31. France microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 32. France microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 33. France microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 34. France microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 35. Spain microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 36. Spain microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 37. Spain microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 38. Spain microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 39. Italy microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 40. Italy microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 41. Italy microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 42. Italy microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 43. Denmark microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 44. Denmark microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 45. Denmark microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 46. Denmark microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 47. Sweden microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 48. Sweden microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 49. Sweden microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 50. Sweden microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 51. Norway microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 52. Norway microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 53. Norway microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 54. Norway microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 55. Asia Pacific microbiome analysis market estimates & forecasts
• Table 56. Asia Pacific microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 57. Asia Pacific microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 58. Asia Pacific microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 59. Asia Pacific microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 60. China microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 61. China microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 62. China microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 63. China microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 64. Japan microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 65. Japan microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 66. Japan microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 67. Japan microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 68. India microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 69. India microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 70. India microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 71. India microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 72. South Korea microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 73. South Korea microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 74. South Korea microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 75. South Korea microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 76. Australia microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 77. Australia microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 78. Australia microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 79. Australia microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 80. Thailand microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 81. Thailand microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 82. Thailand microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 83. Thailand microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 84. Latin America microbiome analysis market estimates & forecasts
• Table 85. Latin America microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 86. Latin America microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 87. Latin America microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 88. Latin America microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 89. Brazil microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 90. Brazil microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 91. Brazil microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 92. Brazil microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 93. Argentina microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 94. Argentina microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 95. Argentina microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 96. Argentina microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 97. MEA microbiome analysis market estimates & forecasts
• Table 98. MEA microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 99. MEA microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 100. MEA microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 101. MEA microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 102. South Africa microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 103. South Africa microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 104. South Africa microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 105. South Africa microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 106. Saudi Arabia microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 107. Saudi Arabia microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 108. Saudi Arabia microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 109. Saudi Arabia microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 110. UAE microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 111. UAE microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 112. UAE microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 113. UAE microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)
• Table 114. Kuwait microbiome analysis market estimates & forecasts, by product & services, 2018 - 2030 (USD Million)
• Table 115. Kuwait microbiome analysis market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
• Table 116. Kuwait microbiome analysis market estimates & forecasts, by application type, 2018 - 2030 (USD Million)
• Table 117. Kuwait microbiome analysis market estimates & forecasts, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market snapshot
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market trends & outlook
• Fig. 7 Market segmentation & scope
• Fig. 8 Market driver relevance analysis (Current & future impact)
• Fig. 9 Market restraint relevance analysis (Current & future impact)
• Fig. 10 PESTLE Analysis
• Fig. 11 Porter's Five Forces Analysis
• Fig. 12 Strategy framework
• Fig. 13 Participant categorization
• Fig. 14 Microbiome Analysis market: Product & Services outlook key takeaways
• Fig. 15 Microbiome Analysis market: Product & Services movement analysis
• Fig. 16 Instruments market, 2018 - 2030 (USD Million)
• Fig. 17 Consumables market, 2018 - 2030 (USD Million)
• Fig. 18 Service market, 2018 - 2030 (USD Million)
• Fig. 19 Microbiome Analysis market: Technology outlook key takeaways
• Fig. 20 Microbiome Analysis market: Technology movement analysis
• Fig. 21 16S rRNA Sequencing market, 2018 - 2030 (USD Million)
• Fig. 22 Shotgun Metagenomics market, 2018 - 2030 (USD Million)
• Fig. 23 Metatranscriptomics market, 2018 - 2030 (USD Million)
• Fig. 24 Other markets, 2018 - 2030 (USD Million)
• Fig. 25 Microbiome Analysis market: Application type outlook key takeaways
• Fig. 26 Microbiome Analysis market: Application type movement analysis
• Fig. 27 Disease Application market, 2018 - 2030 (USD Million)
• Fig. 28 Gastrointestinal disorders market, 2018 - 2030 (USD Million)
• Fig. 29 Metabolic disorders market, 2018 - 2030 (USD Million)
• Fig. 30 Infectious diseases market, 2018 - 2030 (USD Million)
• Fig. 31 Oncology market, 2018 - 2030 (USD Million)
• Fig. 32 Other markets, 2018 - 2030 (USD Million)
• Fig. 33 Research Application market, 2018 - 2030 (USD Million)
• Fig. 34 Microbiome Analysis market: End Use outlook key takeaways
• Fig. 35 Microbiome Analysis market: End Use movement analysis
• Fig. 36 Biopharmaceutical & Pharmaceutical Companies market, 2018 - 2030 (USD Million)
• Fig. 37 Pharmaceuticals market, 2018 - 2030 (USD Million)
• Fig. 38 Biopharmaceutical & Pharmaceutical Companies devices market, 2018 - 2030 (USD Million)
• Fig. 39 CROs & CMOs market, 2018 - 2030 (USD Million)
• Fig. 40 Academic & Research Institutes market, 2018 - 2030 (USD Million)
• Fig. 41 Microbiome Analysis market, by region, 2018 - 2030 (USD Million)
• Fig. 42 North America microbiome analysis market, by country, 2018 - 2030 (USD Million)
• Fig. 43 U.S. microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 44 Canada microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 45 Mexico microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 46 Europe microbiome analysis market, by country, 2018 - 2030 (USD Million)
• Fig. 47 UK microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 48 Germany microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 49 France microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 50 Italy microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 51 Spain microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 52 Denmark microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 53 Sweden microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 54 Norway microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 55 Asia Pacific microbiome analysis market, by country, 2018 - 2030 (USD Million)
• Fig. 56 Japan microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 57 China microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 58 India microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 59 Australia microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 60 South Korea microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 61 Thailand microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 62 Latin America microbiome analysis market, by country, 2018 - 2030 (USD Million)
• Fig. 63 Brazil microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 64 Argentina microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 65 Middle East & Africa microbiome analysis market, by country, 2018 - 2030 (USD Million)
• Fig. 66 South Africa microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 67 Saudi Arabia microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 68 UAE microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 69 Kuwait microbiome analysis market, 2018 - 2030 (USD Million)
• Fig. 70 Key companies profiled

Microbiome Analysis Market Growth & Trends:

The global microbiome analysis market size is projected to reach USD 2.26 billion by 2030, and is projected to grow at a CAGR of 10.47% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is driven by rising demand for personalized medicine, increasing chronic disease prevalence, expanding drug development applications, and technological advancements in sequencing and bioinformatics. Strategic collaborations and outsourcing to CROs/CMOs are further accelerating market expansion across both research and clinical domains.

The microbiome analysis market is rapidly evolving, driven by increased collaboration between academia, industry, and regulatory bodies. Innovations in data analytics, sequencing technology, and machine learning are enhancing the accuracy and scalability of microbiome research. Moreover, the growing understanding of the human microbiome's role in health and disease drives investment and innovation in microbiome analysis technologies. This market is experiencing strong momentum due to its wide applications in disease diagnostics, personalized medicine, drug development, and nutritional studies.

Advances in next-generation sequencing (NGS), bioinformatics, and metabolomics have significantly enhanced the precision and accessibility of microbiome analysis. These developments enable researchers and clinicians to uncover microbial signatures linked to inflammatory bowel disease, obesity, diabetes, cancer, and neurological disorders. As a result, microbiome research is transitioning from academic institutions to clinical and commercial use cases.

However, market growth is restrained by the lack of standardization in methodologies, limited clinical validation, and regulatory ambiguity. High costs associated with advanced multi-omics technologies and complex data interpretation also hinder widespread adoption. Additionally, concerns around data privacy, particularly in direct-to-consumer testing, and skepticism among clinicians due to inconsistent outcomes continue to challenge the integration of microbiome analysis into mainstream healthcare and diagnostics.

Microbiome Analysis Market Report Highlights:

• Based on product & services, consumables dominated the market with a revenue share of 46.47% in 2024. This dominance is primarily due to the recurring demand for reagents, kits, and other lab materials essential for DNA extraction, library preparation, and amplification. However, services are anticipated to grow at the fastest CAGR of 11.55% over the forecast period.
• Based on technology, 16S rRNA sequencing led the market in 2024, attributed to its cost-effectiveness, widespread academic and clinical research adoption, and reliability in identifying bacterial communities across diverse sample types. However, shotgun metagenomics is anticipated to grow at the fastest CAGR over the forecast period.
• Based on application, research applications led the microbiome analysis market in 2024. This growth is driven by increased academic funding and rising interest in microbiome-based disease mechanisms. However, disease application is anticipated to grow at the fastest CAGR over the forecast period.
• Based on end use, academic & research institutes led the microbiome analysis market in 2024. Their dominance is attributed to the robust research funding, extensive microbiome studies, and access to advanced sequencing technologies. However, CROs & CMOs are anticipated to grow at the fastest CAGR over the forecast period.
• Based on region, the North America region dominated the microbiome analysis market with a 42.81% share in 2024, driven by strong research infrastructure, high healthcare spending, and the presence of key market players and advanced sequencing facilities. Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Services Segment
  • 1.2.2. Technology Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Advancements in sequencing technologies
    • 3.2.1.2. Expansion of microbiome research programs
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High complexity of data analysis
• 3.3. Microbiome Analysis Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Microbiome Analysis Market: Product & Services Business Analysis

• 4.1. Product & Services Segment Dashboard
• 4.2. Global Microbiome Analysis Market Product & Services Movement Analysis
• 4.3. Global Microbiome Analysis Market Size & Trend Analysis, by Product & Services, 2018 to 2030 (USD Million)
• 4.4. Instruments
  • 4.4.1. Global Instruments Market, 2018 - 2030 (USD Million)
• 4.5. Consumables
  • 4.5.1. Global Consumables Market, 2018 - 2030 (USD Million)
• 4.6. Services
  • 4.6.1. Global Services Market, 2018 - 2030 (USD Million)

Chapter 5. Microbiome Analysis Market: Technology Business Analysis

• 5.1. Technology Segment Dashboard
• 5.2. Global Microbiome Analysis Market Technology Movement Analysis
• 5.3. Global Microbiome Analysis Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 5.4. 16S rRNA Sequencing
  • 5.4.1. Global 16S rRNA Sequencing Market, 2018 - 2030 (USD Million)
• 5.5. Shotgun Metagenomics
  • 5.5.1. Global Shotgun Metagenomics Market, 2018 - 2030 (USD Million)
• 5.6. Metatranscriptomics
  • 5.6.1. Global Metatranscriptomics Market, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 6. Microbiome Analysis Market: Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Global Microbiome Analysis Market Application Movement Analysis
• 6.3. Global Microbiome Analysis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Disease Application
  • 6.4.1. Global Disease Application Market, 2018 - 2030 (USD Million)
  • 6.4.2. Gastrointestinal Disorders
    • 6.4.2.1. Global Gastrointestinal Disorders Market, 2018 - 2030 (USD Million)
  • 6.4.3. Metabolic Disorders
    • 6.4.3.1. Global Metabolic Disorders Market, 2018 - 2030 (USD Million)
  • 6.4.4. Infectious Diseases
    • 6.4.4.1. Global Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 6.4.5. Oncology
    • 6.4.5.1. Global Oncology Market, 2018 - 2030 (USD Million)
  • 6.4.6. Others
    • 6.4.6.1. Global Others Market, 2018 - 2030 (USD Million)
• 6.5. Research Application
  • 6.5.1. Global Research Application Market, 2018 - 2030 (USD Million)

Chapter 7. Microbiome Analysis Market: End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global Microbiome Analysis Market End Use Movement Analysis
• 7.3. Global Microbiome Analysis Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Biopharmaceutical & Pharmaceutical Companies
  • 7.4.1. Global Biopharmaceutical & Pharmaceutical Companies Devices Market, 2018 - 2030 (USD Million)
• 7.5. CROs & CMOs
  • 7.5.1.1. Global CROs & CMOs Market, 2018 - 2030 (USD Million)
• 7.6. Academic & Research Institutes
  • 7.6.1.1. Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Global Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Microbiome Analysis Market: Region Estimates & Trend Analysis

• 8.1. North America
  • 8.1.1. North America market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.1.2. U.S.
    • 8.1.2.1. Key country dynamics
    • 8.1.2.2. Competitive scenario
    • 8.1.2.3. Regulatory Framework
    • 8.1.2.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.1.3. Canada
    • 8.1.3.1. Key country dynamics
    • 8.1.3.2. Competitive scenario
    • 8.1.3.3. Regulatory Framework
    • 8.1.3.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.1.4. Mexico
    • 8.1.4.1. Key country dynamics
    • 8.1.4.2. Competitive scenario
    • 8.1.4.3. Regulatory Framework
    • 8.1.4.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
• 8.2. Europe
  • 8.2.1. Europe market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.2. UK
    • 8.2.2.1. Key country dynamics
    • 8.2.2.2. Competitive scenario
    • 8.2.2.3. Regulatory Framework
    • 8.2.2.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.3. Germany
    • 8.2.3.1. Key country dynamics
    • 8.2.3.2. Competitive scenario
    • 8.2.3.3. Regulatory Framework
    • 8.2.3.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.4. France
    • 8.2.4.1. Key country dynamics
    • 8.2.4.2. Competitive scenario
    • 8.2.4.3. Regulatory Framework
    • 8.2.4.4. France market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.5. Italy
    • 8.2.5.1. Key country dynamics
    • 8.2.5.2. Competitive scenario
    • 8.2.5.3. Regulatory Framework
    • 8.2.5.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.6. Spain
    • 8.2.6.1. Key country dynamics
    • 8.2.6.2. Competitive scenario
    • 8.2.6.3. Regulatory Framework
    • 8.2.6.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.7. Norway
    • 8.2.7.1. Key country dynamics
    • 8.2.7.2. Competitive scenario
    • 8.2.7.3. Regulatory Framework
    • 8.2.7.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.8. Sweden
    • 8.2.8.1. Key country dynamics
    • 8.2.8.2. Competitive scenario
    • 8.2.8.3. Regulatory Framework
    • 8.2.8.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.2.9. Denmark
    • 8.2.9.1. Key country dynamics
    • 8.2.9.2. Competitive scenario
    • 8.2.9.3. Regulatory Framework
    • 8.2.9.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
• 8.3. Asia Pacific
  • 8.3.1. Asia Pacific market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3.2. Japan
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Competitive scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3.3. China
    • 8.3.3.1. Key country dynamics
    • 8.3.3.2. Competitive scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. China market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3.4. India
    • 8.3.4.1. Key country dynamics
    • 8.3.4.2. Competitive scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. India market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3.5. Thailand
    • 8.3.5.1. Key country dynamics
    • 8.3.5.2. Competitive scenario
    • 8.3.5.3. Regulatory Framework
    • 8.3.5.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3.6. South Korea
    • 8.3.6.1. Key country dynamics
    • 8.3.6.2. Competitive scenario
    • 8.3.6.3. Regulatory Framework
    • 8.3.6.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.3.7. Australia
    • 8.3.7.1. Key country dynamics
    • 8.3.7.2. Competitive scenario
    • 8.3.7.3. Regulatory Framework
    • 8.3.7.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
• 8.4. Latin America
  • 8.4.1. Latin America market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.4.2. Brazil
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.4.3. Argentina
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
• 8.5. Middle East & Africa
  • 8.5.1. Middle East & Africa market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5.2. South Africa
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5.3. Saudi Arabia
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5.4. UAE
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
  • 8.5.5. Kuwait
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. Genetic Analysis AS
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product & Services Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Zymo Research Corporation
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product & Services Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Microbiome Insights
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product & Services Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. . Viome Life Sciences, Inc.
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product & Services Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Microba Life Science
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product & Services Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Luxia Scientific
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product & Services Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. DNA Genotek
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product & Services Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Sun Genomics
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product & Services Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. CosmosID
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product & Services Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. MaaT Pharma
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product & Services Benchmarking
    • 9.4.10.4. Strategic Initiatives